These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16783081)

  • 1. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
    Tsartsidze E; Betaneli M
    Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
    Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
    Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
    J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biology and differentiation of lymphocytes in the classification of lymphomas].
    Mariuzzi G; Di Loreto C; Mariuzzi L
    Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.
    Jalkanen S; Joensuu H; Söderström KO; Klemi P
    J Clin Invest; 1991 May; 87(5):1835-40. PubMed ID: 2022749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic expression of non-Hodgkin's lymphomas in China.
    Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
    J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in non-Hodgkin's lymphoma study in Japan].
    Shimoyama M
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3169-88. PubMed ID: 2904243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
    Armitage JO; Vose JM; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec DF
    J Clin Oncol; 1989 Dec; 7(12):1783-90. PubMed ID: 2585020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-immunoblastic lymphoma mimicking B-immunoblastic lymphoma.
    Swanson S; Innes DJ; Frierson HF; Hess CE
    Arch Pathol Lab Med; 1987 Nov; 111(11):1077-80. PubMed ID: 2959240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
    Rasmuson T; Björk GR
    Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphomas: contemporary classification and correlates.
    Howard DR; Batsakis JG
    Ann Otol Rhinol Laryngol; 1985; 94(3):326-8. PubMed ID: 3874578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of non-Hodgkin's lymphomas: facts and perspectives].
    Kelényi G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(5):585-605. PubMed ID: 85568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathohistology of non-Hodgkin's lymphomas: recent progress].
    Kelényi G
    Z Gesamte Inn Med; 1979 Jul; 34(13):162-6. PubMed ID: 317195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
    Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of lymphoma in Malaysia: a histopathological study utilizing immunophenotyping.
    Mancer K
    Malays J Pathol; 1990 Dec; 12(2):77-88. PubMed ID: 2102968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.